OMNISCAN (GE Healthcare Inc.)
Welcome to the PulseAid listing for the OMNISCAN drug offered from GE Healthcare Inc.. This Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | GE Healthcare Inc. |
NON-PROPRIETARY NAME: | gadodiamide |
SUBSTANCE NAME: | GADODIAMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2002-04-19 |
END MARKETING DATE: | 0000-00-00 |
OMNISCAN HUMAN PRESCRIPTION DRUG Details:
Item Description | OMNISCAN from GE Healthcare Inc. |
LABELER NAME: | GE Healthcare Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 287(mg/mL) |
START MARKETING DATE: | 2002-04-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0407-0690_39df0de4-7294-4155-8c97-5ab64b384613 |
PRODUCT NDC: | 0407-0690 |
APPLICATION NUMBER: | NDA020123 |
Other GADODIAMIDE Pharmaceutical Manufacturers / Labelers: